|
1
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992.PubMed/NCBI
|
|
2
|
Salceda S and Caro J: Hypoxia-inducible
factor 1alpha (HIF-1alpha) protein is rapidly degraded by the
ubiquitin-proteasome system under normoxic conditions. Its
stabilization by hypoxia depends on redox-induced changes. J Biol
Chem. 272:22642–22647. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JW, Bae SH, Jeong JW, Kim SH and Kim
KW: Hypoxia-inducible factor (HIF-1)alpha: Its protein stability
and biological functions. Exp Mol Med. 36:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koong AC, Mehta VK, Le QT, et al:
Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol
Biol Phys. 48:919–922. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhong H, De Marzo AM, Laughner E, et al:
Overexpression of hypoxia-inducible factor 1alpha in common human
cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
6
|
Fukuda R, Hirota K, Fan F, Jung YD, Ellis
LM and Semenza GL: Insulin-like growth factor 1 induces
hypoxia-inducible factor 1-mediated vascular endothelial growth
factor expression, which is dependent on MAP kinase and
phosphatidylinositol 3-kinase signaling in colon cancer cells. J
Biol Chem. 277:38205–38211. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang F, Li SS, Segersvärd R, Strömmer L,
Sundqvist KG, Holgersson J and Permert J: Hypoxia inducible
factor-1 mediates effects of insulin on pancreatic cancer cells and
disturbs host energy homeostasis. Am J Pathol. 170:469–477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Funasaka T, Yanagawa T, Hogan V and Raz A:
Regulation of phosphoglucose isomerase/autocrine motility factor
expression by hypoxia. FASEB J. 19:1422–1430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lyshchik A, Higashi T, Hara T, et al:
Expression of glucose transporter-1, hexokinase-II, proliferating
cell nuclear antigen and survival of patients with pancreatic
cancer. Cancer Invest. 25:154–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakagawa A, Samols E and Stagner JI:
Exocrine interstitial insulin and somatostatin in the perfused dog
pancreas. Am J Physiol. 264:G728–G734. 1993.PubMed/NCBI
|
|
12
|
Gallagher EJ and LeRoith D: The
proliferating role of insulin and insulin-like growth factors in
cancer. Trends Endocrinol Metab. 21:610–618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trajkovic-Arsic M, Kalideris E and Siveke
JT: The role of insulin and IGF system in pancreatic cancer. J Mol
Endocrinol. 50:R67–R74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang F, Larsson J, Adrian TE, Gasslander T
and Permert J: In vitro influences between pancreatic
adenocarcinoma cells and pancreatic islets. J Surg Res. 79:13–19.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding XZ, Fehsenfeld DM, Murphy LO, Permert
J and Adrian TE: Physiological concentrations of insulin augment
pancreatic cancer cell proliferation and glucose utilization by
activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression.
Pancreas. 21:310–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Jia X, Duan Y, Xiao H, Sundqvist
KG, Permert J and Wang F: Excess glucose induces hypoxia-inducible
factor-1α in pancreatic cancer cells and stimulates glucose
metabolism and cell migration. Cancer Biol Ther. 14:428–435. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao H, Li S, Zhang D, Liu T, Yu M and
Wang F: Separate and concurrent use of 2-deoxy-D-glucose and
3-bromopyruvate in pancreatic cancer cells. Oncol Rep. 29:329–334.
2013.PubMed/NCBI
|
|
18
|
Graham ML, Janecek JL, Kittredge JA,
Hering BJ and Schuurman HJ: The streptozotocin-induced diabetic
nude mouse model: Differences between animals from different
sources. Comp Med. 61:356–360. 2011.PubMed/NCBI
|
|
19
|
Wang F, Larsson J, Abdiu A, Gasslander T,
Westermark P, Adrian TE and Permert J: Dissociated secretion of
islet amyloid polypeptide and insulin in serum-free culture media
conditioned by human pancreatic adenocarcinoma cell lines. Int J
Pancreatol. 21:157–164. 1997.PubMed/NCBI
|
|
20
|
Wang F, Kumagai-Braesch M, Herrington MK,
Larsson J and Permert J: Increased lipid metabolism and cell
turnover of MiaPaCa2 cells induced by high fat diet in an
orthotopic system. Metabolism. 58:1131–1136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Asano N, Manabe T, Imanishi K and Tobe T:
Changes of A, B and D cells in Langerhans islets in pancreatic
cancers of hamsters. Nihon Geka Hokan. 60:233–242. 1991.PubMed/NCBI
|
|
22
|
Torosian MH, Bartlett DL, Chatzidakis C
and Stein TP: Effect of tumor burden on futile glucose and lipid
cycling in tumor-bearing animals. J Surg Res. 55:68–73. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lundholm K, Edström S, Karlberg I, Ekman L
and Scherstén T: Glucose turnover, gluconeogenesis from glycerol,
and estimation of net glucose cycling in cancer patients. Cancer.
50:1142–1150. 1982. View Article : Google Scholar : PubMed/NCBI
|
